High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

Influenza vaccination can be less effective in patients treated with immunosuppressive therapy. However, little is known about the effects of ustekinumab; an anti-IL-12/23 agent used to treat Crohn’s disease (CD), on vaccination response. In this prospective study, we assessed immune responses to se...

Full description

Bibliographic Details
Main Authors: Laura Doornekamp, Rogier L. Goetgebuer, Katharina S. Schmitz, Marco Goeijenbier, C. Janneke van der Woude, Ron Fouchier, Eric C.M. van Gorp, Annemarie C. de Vries
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Vaccines
Subjects:
ustekinumab
influenza vaccine
Crohn’s disease
Online Access:https://www.mdpi.com/2076-393X/8/3/455

Internet

https://www.mdpi.com/2076-393X/8/3/455

Similar Items